AbbVie (ABBV): analysis and statistics
Return, volatility, Sharpe ratio and risk for AbbVie, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $257.51 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +24.20% |
| Total return over period | +90.95% |
| Annualized volatility | 24.43% |
| Sharpe ratio | 0.84 |
| Sortino ratio | 1.18 |
| Max drawdown | -20.74% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.67% |
| Correlation with the S&P 500 | 0.18 |
| Period range | $125.30 – $263.30 |
| Trading days analyzed | 752 |
Over the last 3.0 years, AbbVie (ABBV) has posted an annualized return of +24.20% with annual volatility of 24.43%, a Sharpe ratio of 0.84. Its worst stretch (max drawdown from a peak) was -20.74%. Its correlation with the S&P 500 is 0.18, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how ABBV would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with ABBV →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio